Treatment of stage I non-small cell lung carcinoma

Chest

Volumn 123, Issue 1 SUPPL., 2003, Pages 181S-187S

  Smythe, W Roy ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chemotherapy; Lung cancer; Radiation therapy; Stage I; Surgery

Indexed keywords

CISPLATIN;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL TRIAL; COBALT THERAPY; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE DISSECTION; MEDIASTINUM LYMPH NODE; META ANALYSIS; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; REVIEW; THORACOTOMY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0037246717     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0012-3692(15)32996-2     Document Type: Review

References (48)

1. Naruke T, Goya T, Tsuchiya R, et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. Thorac Cardiovasc Surg 1988; 96:440-447
2. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111:1710-1717
3. American Joint Committee on Cancer Lung. In: Fleming ID, Cooper JS, Henson DE, et al, eds. AJCC Cancer Staging Handbook. Philadelphia, PA: Lippincott-Raven, 1997; 117-127
4. Ries LA, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 2000; 88:2398-2424
5. Holmes EC, Gail M. Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma. Lung Cancer Study Group. J Clin Oncol 1986; 4:710-715
6. Niiranen A, Niitamokorhonen S, Kouri M, et al. Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study. J Clin Oncol 1992; 10:1927-1932
7. Feld R, Rubinstein L, Thomas PA, et al. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. J Natl Cancer Inst 1993; 85:299-306
8. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995; 311:899-909
9. Imaizumi M. A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study). The Study Group of Adjuvant Chemotherapy for Lung Cancer. Eur J Surg Oncol 1995; 21:69-77
10. Wada H, Hitomi S, Teramatsu T, et al. Adjuvant chemotherapy after complete resection in non-small cell lung cancer. J Clin Oncol 1996; 14:1048-1054
11. Roth JA, Swisher SG, Merritt JA, et al. Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement. Semin Oncol 1998; 25(3 Suppl 8):33-37
12. Rosell R, Gomez-Codina J, Camps C, et al. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer 1999; 26:7-14
13. Pisters KMW, Ginsberg RJ, Giroux DJ, et al. Induction chemotherapy before surgery for early-stage lung cancer: a novel approach. Thorac Cardiovasc Surg 2000; 119:429-439
14. D'Amico TA, Aloia TA, Moore MB, et al. Predicting the sites of metastases from lung cancer using molecular biologic markers. Ann Thorac Surg 2001; 72:1144-1148
15. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group. Lancet 1998; 352:257-263
16. Shields TW. Preoperative radiation therapy in the treatment of bronchial carcinoma. Cancer 1972; 30:1388-1394
17. Graham PH, Gebski VJ, Langlands AO. Radical radiotherapy for early nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1995; 31:261-266
18. Morita K, Fuwa N, Suzuki Y, et al. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients. Radiother Oncol 1997; 42:31-36
19. Kupelian PA, Komaki R, Allen P. Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys 1996; 36:607-613
20. Uematsu M, Shioda A, Suda A, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 2001; 51:666-670
21. Bush DA, Slater JD, Bonnet R, et al. Proton-beam radiother-apy for early-stage lung cancer. Chest 1999; 116:1313-1319
22. Lad TE. Postsurgical adjuvant therapy in stages I, II, and IIIA non-small cell lung cancer. Hematol Oncol Clin North Am 1990; 4:1111-1119
23. Silvestri GA, Handy J, Lackland D, et al. Specialists achieve better outcomes than generalists for lung cancer surgery. Chest 1998; 114:675-680
24. Laroche C, Wells F, Coulden R, et al. Improving surgical resection rate in lung cancer. Thorax 1998; 53:445-449
25. Schroen AT, Detterbeck FC, Crawford R, et al. Beliefs among pulmonologists and thoracic surgeons in the therapeutic approach to non-small cell lung cancer. Chest 2000; 118:129-137
26. Bach PB, Cramer LD, Schrag D, et al. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med 2001; 345:181-188
27. Jensik RJ, Faber LP, Kittle CF. Segmental resection for bronchogenic carcinoma. Ann Thorac Surg 1979; 28:475-483
28. Errett LE, Wilson J, Chiu RC, et al. Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor-risk patients. Thorac Cardiovasc Surg 1985; 90:656-661
29. Temeck BK, Schafer PW, Saini N. Wedge resection for bronchogenic carcinoma in high-risk patients. South Med J 1992; 85:1-1083
30. Weissberg D, Straehley CJ, Scully NM, et al. Less than lobar resections for bronchogenic carcinoma. Scand Thorac Cardiovasc Surg 1993; 27:121-126
31. Warren WH, Faber LP. Segmentectomy vs lobectomy in patients with stage I pulmonary carcinoma. Thorac Cardiovasc Surg 1994; 107:1087-1094
32. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence in second primary tumors in resected stage I lung cancer. Thorac Cardiovasc Surg 1995; 89:836-841
33. Ginsberg RJ, Rubinstein LV. A randomized comparative trial of lobectomy vs limited resection for patients with T1NO non-small cell lung cancer. Lung Cancer 1995; 7:83-88
34. Giudicelli R, Thomas P, Lonjon T, et al. Video-assisted minithoracotomy vs muscle-sparing thoracotomy for performing lobectomy. Ann Thorac Surg 1994; 58:712-717
35. Kirby TJ, Rice TW. Thoracoscopic lobectomy. Ann Thorac Surg 1993; 56:784-786
36. Lewis RJ. The role of video-assisted thoracic surgery for carcinoma of the lung: wedge resection to lobectomy by simultaneous individual stapling. Ann Thorac Surg 1993; 56:762-768
37. McKenna RJ Jr. Lobectomy by video-assisted thoracic surgery with mediastinal node sampling for lung cancer. Thorac Cardiovasc Surg 1994; 107:879-881
38. Roviaro G, Varoli F, Vergani C, et al. Video-assisted thora-coscopic surgery (VATS) major pulmonary resections: the Italian experience. Semin Thorac Cardiovasc Surg 1998; 10:313-320
39. Nomori H, Horio H, Naruke T, et al. What is the advantage of a thoracoscopic lobectomy over a limited thoracotomy procedure for lung cancer surgery? Ann Thorac Surg 2001; 72:879-884
40. Keller SM, Adak S, Wagner H, et al. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg 2000; 70:358-365
41. Izbicki JR, Thetter O, Habekost M, et al. Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: a randomized controlled trial. Br J Surg 1994; 81:229-235
42. Sugi K, Nawata K, Fujita N, et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter. World J Surg 1998; 22:290-294
43. Ohta Y, Oda M, Wu J, et al. Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis. Thorac Cardiovasc Surg 2001; 122:900-906
44. Takizawa T, Terashima M, Koike T, et al. Lymph node metastasis in small peripheral adenocarcinoma of the lung. Thorac Cardiovasc Surg 1998; 116:276-280
45. Liptay MJ, Masters GA, Winchester DJ, et al. Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Surg 2000; 70:384-389
46. Little AG, DeHoyos A, Kirgan DM, et al. Intraoperative lymphatic mapping for non-small cell lung cancer: the sentinel node technique. Thorac Cardiovasc Surg 1999; 117:220-234
47. Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review. Thorax 2001; 56:628-638
48. Thirion P, et al. Three-dimensional conformal radiation therapy (3DCRT) permits radiobiological dose escalation for non-small cell lung cancer (NSCLC): preliminary results of a phase I/II trial [abstract]. Proc Am Soc Clin Oncol 2001; 20:344a